Clinical Trial Management System (CTMS) Market

o Clinical Trial Management System Market Worth $3.59

Clinical Trial Management System (CTMS) Market 2023-2030 Meticulous Research®– a leading global market research company, published a research report titled “Clinical Trial Management System (CTMS) Market by Component (Software, Service), Type (Enterprise, Site), Mode of Delivery (Web, Cloud, On-premise), End User (CRO, Pharmaceutical & Biotech, Medical Device Companies) - Global Forecast to 2030.” Download Free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5456 According to this latest publication from Meticulous Research, the global clinical trial management system (CTMS) market is expected to grow at a CAGR of 13.5% to reach $3.59 billion by 2030. A surge in the number of clinical trials, increasing adoption of healthcare IT, and rising government support are the factors driving the market growth. Furthermore, increasing the adoption of AI-based CTMS will likely offer better growth opportunities for market expansion. Moreover, the growing trend of integrated CTMS solutions is expected to support market growth. However, the lack of skilled healthcare professionals to handle advanced digital solutions poses a major challenge to the growth of the CTMS market. Clinical Trial Management System Market: Future Outlook The global clinical trial management system market study presents historical market data in terms of values (2021 and 2022), estimated current data (2023), and forecasts it for 2030 – by Component (Software and Service), Type (Enterprise-based and Site- based), Mode of Delivery (Web-based, Cloud-based, and On-premise), End User (Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Medical Device Companies, and Other End Users), and Geography. The study also evaluates industry competitors and analyzes their market share at global and regional levels. Based on component, the market is segmented into software and service. The software segment is expected to account for the largest market share in 2023, owing to the increase in research & development expenditure, rise in the number of clinical trials, and surge in the adoption of clinical trial management system software. Based on type, the enterprise-based CTMS is expected to account for the largest share of the market in 2023. Control and connection within the organization, streamlining and simplifying processes, and cost reduction contribute to the largest market share. Speak analyst/cp_id=5456 to analyst: https://www.meticulousresearch.com/speak-to- Based on end user, the contract research organizations (CROs) segment is expected to account for the largest share of the market in 2023. The large share can be attributed to the increased outsourcing of clinical trials by various healthcare stakeholders, Page 1 of 6 © Meticulous Research| sales@meticulousresearch.com

Clinical Trial Management System (CTMS) Market 2023-2030 including manufacturers, animal health companies, and a few academic institutes. pharmaceutical & biotechnology companies, medical device Geographic Review This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa. Asia- Pacific is estimated to grow at the highest CAGR during the forecast period. Increasing outsourcing of clinical trials by major and minor stakeholders, the rising number of clinical trials in the region, and the availability of a large patient pool drive the demand for clinical trial management systems (CTMS). Quick Buy:https://www.meticulousresearch.com/Checkout/50827972 Key Players The key players operating in the global clinical trial management system (CTMS) market are Oracle Corporation (U.S.), SimpleTrials (U.S.), LABORATORY CORPORATION OF AMERICA HOLDINGS (U.S.), Wipro Limited (India), Advarra, Inc. (U.S.), RealTime Software Solutions, LLC (U.S.), Datatrak International, Inc. (U.S.), Clario (U.S.), Dassault Systèmes (France), Veeva Systems Inc. (U.S.), PHARMASEAL (U.K.), MasterControl Inc. (U.S.), Calyx (U.S.), IQVIA HOLDINGS INC. (U.S.), and DSG, Inc. (U.S.) among others. Key questions answered in the report- •Which are the high-growth market segments in terms of component, type, mode of delivery, end user, and regions/countries? •What was the historical market for clinical trial management systems across the globe? •What are the market forecasts and estimates for the period 2023–2030? •What are the major drivers, restraints, challenges, opportunities, and trends in the clinical trial management system market? •Who are the major players in the global clinical trial management system market? •What is the competitive landscape, and who are the market leaders in the global clinical trial management system market? •What are the recent developments in the clinical trial management system market? Page 2 of 6 © Meticulous Research| sales@meticulousresearch.com

Clinical Trial Management System (CTMS) Market 2023-2030 •What are the different strategies adopted by the major players in the clinical trial management system market? •What are the geographical trends and high-growth regions/countries? Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulousresearch Page 3 of 6 © Meticulous Research| sales@meticulousresearch.com

Clinical Trial Management System (CTMS) Market 2023-2030 Page 4 of 6 © Meticulous Research| sales@meticulousresearch.com

Clinical Trial Management System (CTMS) Market